EC Number | Application | Comment | Organism |
---|---|---|---|
2.1.1.5 | medicine | upregulation of BHMT may indicate an increased choline requirement in the diabetic rat | Rattus norvegicus |
2.1.1.20 | medicine | diabetes increases the activity and abundance of GNMT, lack of dietary folate results in the highest activity of GNMT in diabetic rats without the abundance of the protein being altered | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.20 | additional information | folate-containing diets attenuate GNMT activity in diabetic rats but are without effect on abundance | Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.5 | Rattus norvegicus | - |
- |
- |
2.1.1.20 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.5 | liver | BHMT mRNA and activity increases about 2fold in diabetic rats compared with the nondiabetic animals | Rattus norvegicus | - |
2.1.1.20 | liver | activity of GNMT is increased about 2fold in diabetic liver | Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.5 | L-homocysteine + betaine | folate-independent remethylation of homocysteine | Rattus norvegicus | L-methionine + dimethylglycine | - |
? | |
2.1.1.20 | S-adenosyl-L-methionine + glycine | - |
Rattus norvegicus | S-adenosyl-L-homocysteine + sarcosine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.5 | BHMT | - |
Rattus norvegicus |
2.1.1.20 | GNMT | - |
Rattus norvegicus |